ACTU financials

Actuate Therapeutics (ACTU) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

ACTU income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$22.50M-$22.23M-1.06
2024––-$25.16M-$27.29M-3.26
2023––-$24.97M-$24.74M-17.24